Search Site
01606 871332 | Search

Life Sciences


This sector has over the last decade been our real area of specialism and expertise and we have worked with and advised many customers in the UK and across the world.

With our Life Sciences practice headed by David Stokes, one of the industry’s thought leaders, Percipient have a great deal of experience in the implementation, validation and support of business systems in the Life Sciences industry following best practice.

We recognise that with increased regulations and changes both to key customers and drug approvals processes, the industry is undergoing unprecedented changes. So it’s more important than ever for companies’ processes for drug development, supply chain and distribution to be as efficient as possible.

Some of the benefits to the solutions we deliver include:

  • Bringing new innovative drugs to market.  Even with fewer ‘blockbuster’ drugs and more specialist ‘personalised’ medicines, bringing new products to market can cost billions before seeing a return on investment. Making that process faster, rapidly identifying which drugs will deliver the right returns and efficiently managing the approvals process will bring significant benefits.
  • Pricing pressures. With healthcare budgets under tighter scrutiny, efficient control over operating costs in the production supply chain help you maintain margins to invest in new products
  • Reputation Management. For pharmaceutical companies, a simple mistake can quickly destroy a trust and reputation that’s taken years to build. With drugs being brought to market faster and technology becoming ever-more complex, the ability to respond to product recalls, identify issues and control your processes is vital to maintaining your reputation.
  • Regulatory controls. This is one of the most highly-regulated industries, with a constantly changing framework. So the flexibility to easily meet new regulations – such as combatting fraud through track and trace, serialisation and pedigree – is essential.
  • Greater collaboration. Pressure on R&D costs mean it’s increasingly common for small and large companies, academia, governments and health care providers to collaborate to achieve innovation.

Our solutions can help Life Sciences businesses and organisations achieve all this and more.

Keep up to date